Related references
Note: Only part of the references are listed.The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Transporters
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Nuclear hormone receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Pretransplant 4β-hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation
Thomas Vanhove et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
4-Hydroxycholesterol level significantly correlates with steady-state serum concentration of the CYP3A4 substrate quetiapine in psychiatric patients
Caroline Gjestad et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
4 beta-Hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after induction with rifampicin
Ulf Diczfalusy et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Plasma 4β-Hydroxycholesterol: An Endogenous CYP3A Metric?
D. Tomalik-Scharte et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine
Tiangang Li et al.
JOURNAL OF LIPID RESEARCH (2007)
Pregnane X receptor-agonists down-regulate hepatic ATP-binding cassette transporter A1 and scavenger receptor class B type I
M Sporstol et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription
TG Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Metabolism of 4β-hydroxycholesterol in Humans
K Bodin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
